IL238276B - A composituon comprising bremelanotide for use in treating female sexual dysfunction - Google Patents

A composituon comprising bremelanotide for use in treating female sexual dysfunction

Info

Publication number
IL238276B
IL238276B IL238276A IL23827615A IL238276B IL 238276 B IL238276 B IL 238276B IL 238276 A IL238276 A IL 238276A IL 23827615 A IL23827615 A IL 23827615A IL 238276 B IL238276 B IL 238276B
Authority
IL
Israel
Prior art keywords
bramelnotide
treatment
preparation containing
sexual dysfunction
female sexual
Prior art date
Application number
IL238276A
Other languages
English (en)
Hebrew (he)
Other versions
IL238276A0 (en
Original Assignee
Palatin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50628268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL238276(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palatin Technologies Inc filed Critical Palatin Technologies Inc
Publication of IL238276A0 publication Critical patent/IL238276A0/en
Publication of IL238276B publication Critical patent/IL238276B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
IL238276A 2012-11-05 2015-04-14 A composituon comprising bremelanotide for use in treating female sexual dysfunction IL238276B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722511P 2012-11-05 2012-11-05
US201361770535P 2013-02-28 2013-02-28
PCT/US2013/068386 WO2014071339A2 (en) 2012-11-05 2013-11-05 Uses of bremelanotide in therapy for female sexual dysfunction

Publications (2)

Publication Number Publication Date
IL238276A0 IL238276A0 (en) 2015-06-30
IL238276B true IL238276B (en) 2020-04-30

Family

ID=50628268

Family Applications (1)

Application Number Title Priority Date Filing Date
IL238276A IL238276B (en) 2012-11-05 2015-04-14 A composituon comprising bremelanotide for use in treating female sexual dysfunction

Country Status (23)

Country Link
US (7) US9352013B2 (enExample)
EP (1) EP2916856B2 (enExample)
JP (1) JP6567971B2 (enExample)
KR (1) KR102253526B1 (enExample)
CN (2) CN117860866A (enExample)
AU (1) AU2013337341B2 (enExample)
BR (1) BR112015009936A8 (enExample)
DK (1) DK2916856T4 (enExample)
EA (1) EA032959B9 (enExample)
ES (1) ES2701444T5 (enExample)
FI (1) FI2916856T4 (enExample)
GE (2) GEP20196947B (enExample)
HK (1) HK1211227A1 (enExample)
IL (1) IL238276B (enExample)
MX (1) MX362610B (enExample)
MY (1) MY179755A (enExample)
NZ (1) NZ707246A (enExample)
PH (1) PH12015500915B1 (enExample)
PL (1) PL2916856T5 (enExample)
SG (1) SG11201502949QA (enExample)
UA (1) UA118656C2 (enExample)
WO (1) WO2014071339A2 (enExample)
ZA (1) ZA201503128B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235625B2 (en) * 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
JP4943622B2 (ja) * 2000-05-31 2012-05-30 ノヴォ ノルディスク アー／エス 使い捨て可能で両端が尖った注射針並びにこの使い捨て可能で両端が尖った注射針を有するインシュリン注射システム
AU2002322466B2 (en) 2001-07-11 2007-08-30 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
AU2005313993A1 (en) * 2004-12-09 2006-06-15 West Pharmaceutical Services, Inc. Breech loaded fixed needle syringe and automatic injection device having the same
WO2009120656A1 (en) * 2008-03-24 2009-10-01 Palatin Technologies, Inc. Pharmaceutical for ocular indications
AU2009257631B2 (en) * 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
JP5486690B2 (ja) * 2009-11-16 2014-05-07 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ メラノコルチン受容体リガンドの医薬組成物
NZ602782A (en) * 2010-04-21 2015-07-31 Abbvie Biotechnology Ltd Wearable automatic injection device for controlled delivery of therapeutic agents

Also Published As

Publication number Publication date
US20140378392A1 (en) 2014-12-25
FI2916856T4 (fi) 2024-01-15
KR102253526B1 (ko) 2021-05-18
ES2701444T3 (es) 2019-02-22
GEP20196947B (en) 2019-02-11
DK2916856T3 (en) 2019-01-14
US20220362328A1 (en) 2022-11-17
KR20150081345A (ko) 2015-07-13
CN117860866A (zh) 2024-04-12
PH12015500915A1 (en) 2015-06-29
MX2015005486A (es) 2015-11-13
CN104755094A (zh) 2015-07-01
AU2013337341A1 (en) 2015-05-07
EP2916856A4 (en) 2016-06-22
US10286034B2 (en) 2019-05-14
WO2014071339A2 (en) 2014-05-08
NZ707246A (en) 2019-03-29
ZA201503128B (en) 2016-11-30
WO2014071339A3 (en) 2014-06-12
HK1211227A1 (en) 2016-05-20
EA032959B9 (ru) 2019-11-27
US9352013B2 (en) 2016-05-31
IL238276A0 (en) 2015-06-30
PL2916856T5 (pl) 2024-01-29
GEAP201813826A (en) 2018-10-25
US20210060120A1 (en) 2021-03-04
US20180085425A1 (en) 2018-03-29
AU2013337341B2 (en) 2018-02-22
DK2916856T4 (da) 2024-01-22
MY179755A (en) 2020-11-12
JP2016503406A (ja) 2016-02-04
BR112015009936A2 (pt) 2017-07-11
PL2916856T3 (pl) 2019-02-28
EP2916856A2 (en) 2015-09-16
JP6567971B2 (ja) 2019-08-28
EA032959B1 (ru) 2019-08-30
EA201590760A1 (ru) 2015-10-30
SG11201502949QA (en) 2015-06-29
ES2701444T5 (es) 2024-05-21
UA118656C2 (uk) 2019-02-25
MX362610B (es) 2019-01-28
US9700592B2 (en) 2017-07-11
BR112015009936A8 (pt) 2019-09-17
CA2890081A1 (en) 2014-05-08
US20190216888A1 (en) 2019-07-18
US20150231196A1 (en) 2015-08-20
PH12015500915B1 (en) 2015-06-29
EP2916856B2 (en) 2023-10-18
US20240335502A1 (en) 2024-10-10
EP2916856B1 (en) 2018-09-19

Similar Documents

Publication Publication Date Title
IL285843A (en) Ibrutinib for use in the treatment of chronic graft versus host disease
GB2491118B (en) Cannabinoids for use in the treatment of neuropathic pain
LT2726048T (lt) Seksualinės stimuliacijos įrenginys
GB201115711D0 (en) Phyto-cannabinoids for use in the treatment of cancer
EP2992089A4 (en) Use of anti-cd47 agents to enhance immunization
PT3811943T (pt) Composto para uso no tratamento de distúrbios oculares
PL2717692T3 (pl) Kwasy tetrahydrokannabinol-11-owe do stosowania w leczeniu chorób zwłóknieniowych
EP2888396A4 (en) USE OF WATER COMPONENTS IN CLEANING APPLICATIONS
EP2777680A4 (en) DEVICE FOR FEMALE SEXUAL STIMULATION
PL2838854T3 (pl) Uzdatnianie wody
EP2777679A4 (en) DEVICE FOR MALE SEXUAL STIMULATION
GB201309274D0 (en) Treatment Of Fuel
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
ZA201409343B (en) Water treatment
HRP20180011T1 (hr) Spojevi za uporabu u liječenju filariaza
PT2653448T (pt) Tratamento de água
IL238276B (en) A composituon comprising bremelanotide for use in treating female sexual dysfunction
IL237107A0 (en) Use of adenosine a3 receptor ligands in the treatment of sexual disorders
TWM475277U (en) Sexual massage cup
ES1078486Y (es) Prenda femenina para estimulación sexual
GB201207431D0 (en) Intravaginal treatment of gynacological conditions
GB201110895D0 (en) Therapeutic use
FI20115180L (fi) Koostumus käytettäväksi sairauden hoidossa

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed